Kiora Stock Performance

KPRX
 Stock
  

USD 6.15  0.57  8.48%   

The company secures a Beta (Market Risk) of 1.8686, which conveys a somewhat significant risk relative to the market. Let's try to break down what Kiora's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kiora Pharmaceuticals will likely underperform. Even though it is essential to pay attention to Kiora Pharmaceuticals price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Kiora Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Kiora Pharmaceuticals has an expected return of -0.64%. Please be advised to verify Kiora Pharmaceuticals value at risk, as well as the relationship between the kurtosis and market facilitation index to decide if Kiora Pharmaceuticals performance from the past will be repeated at some point in the near future.
  
Kiora Performance
0 of 100
Over the last 90 days Kiora Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors. ...more

Kiora Price Channel

Quick Ratio1.04
Fifty Two Week Low4.86
Target High Price15.00
Fifty Two Week High93.60
Target Low Price2.50

Kiora Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  1,800  in Kiora Pharmaceuticals on July 2, 2022 and sell it today you would lose (1,170)  from holding Kiora Pharmaceuticals or give up 65.0% of portfolio value over 90 days. Kiora Pharmaceuticals is currently does not generate positive expected returns and assumes 15.834% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Kiora, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 13.95 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.08 per unit of volatility.

Kiora Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Kiora Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Kiora Pharmaceuticals, and traders can use it to determine the average amount a Kiora Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0401

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsKPRX
Estimated Market Risk
 15.83
  actual daily
 
 96 %
of total potential
 
9696
Expected Return
 -0.64
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.04
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Kiora Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kiora Pharmaceuticals by adding it to a well-diversified portfolio.

About Kiora Pharmaceuticals Performance

To evaluate Kiora Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Kiora Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Kiora Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Kiora Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Kiora's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah. Kiora Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.

Things to note about Kiora Pharmaceuticals

Checking the ongoing alerts about Kiora Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Kiora Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Kiora Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

Kiora Pharmaceuticals generated a negative expected return over the last 90 days
Kiora Pharmaceuticals has high historical volatility and very poor performance
Kiora Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 12.06 K. Net Loss for the year was (15.18 M) with loss before overhead, payroll, taxes, and interest of (5.14 M).
Kiora Pharmaceuticals currently holds about 2.43 M in cash with (10.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.07.
Latest headline from www.benzinga.com: US Stocks Turn Lower Dow Dips 175 Points - Avenue Therapeutics , Bellerophon Therapeutics - Benzinga
Please see Correlation Analysis. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for analysis

When running Kiora Pharmaceuticals price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Kiora Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.